T-Butylacetic Acid

T-Butylacetic Acid

SCHEMBL6500330

CC(C)(C)CC(=O)[O-].[Na+]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of T-Butylacetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114469965-A Inhibitor of core fucosyltransferase and application thereof 大连医科大学 2022-05-13 CN disclosed
CN-107406389-B Electrochromic compounds with improved color stability in the free radical state 金泰克斯公司 2021-05-11 CN disclosed
US-10464900-B2 Electrochromic compounds with improved color stability in their radical states GENTEX CORPORATION (US) 2019-11-05 US disclosed
US-20180346421-A1 ELECTROCHROMIC COMPOUNDS WITH IMPROVED COLOR STABILITY IN THEIR RADICAL STATES GENTEX CORPORATION 2018-12-06 US disclosed
US-10040763-B2 Electrochromic compounds with improved color stability in their radical states GENTEX CORPORATION (US) 2018-08-07 US disclosed
EP-3256544-A2 ELECTROCHROMIC COMPOUNDS WITH IMPROVED COLOR STABILITY IN THEIR RADICAL STATES Gentex Corporation (US) 2017-12-20 EP disclosed
WO-2016130712-A2 ELECTROCHROMIC COMPOUNDS WITH IMPROVED COLOR STABILITY IN THEIR RADICAL STATES GENTEX CORPORATION (US) 2016-08-18 WO disclosed
US-20160229803-A1 ELECTROCHROMIC COMPOUNDS WITH IMPROVED COLOR STABILITY IN THEIR RADICAL STATES GENTEX CORPORATION 2016-08-11 US disclosed
US-6908996-B2 Compounds and method for preparing 3-methylcephams IMPERIAL COLLEGE OF LONDON (GB) 2005-06-21 US disclosed
US-6683176-B2 FOR USE IN PRODUCING AMINO ACID DERIVATIVE ANTIBIOTICS COOPER CONSULTING 2004-01-27 US disclosed
EP-1183262-A4 INTERMEDIATES FOR AND SYNTHESIS OF 3-METHYLENE CEPHAMS COOPER CONSULTING INC (US) 2003-04-09 EP disclosed
EP-1183262-A1 INTERMEDIATES FOR AND SYNTHESIS OF 3-METHYLENE CEPHAMS Cooper Consulting Inc. (US) 2002-03-06 EP disclosed
WO-2001060828-A1 INTERMEDIATES FOR AND SYNTHESIS OF 3-METHYLENE CEPHAMS COOPER CONSULTING INC. (US) 2001-08-23 WO disclosed